Brokerage firms currently have a positive stance on shares of Flotek Industries, Inc. (NYSE:FTK). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $10.00 on a short term basis.
At the time of writing, the stock was trading at $6.35. This represents a change from most recent open price of 6.54%. In terms of performance, year to date, the stock is -32.37%. The monthly stock performance comes in at -26.93%. For the quarter, shares are performing at -39.41%. Weekly performance analysis shows the equity at -24.40%.
In taking a look at technical levels, shares are trading -28.61% away from the 50 day simple moving average and -41.60% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -62.49% away from it’s 52- week high and 29.33% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Flotek Industries, Inc.’s RSI stands at 30.43. In looking at volatility levels, the shares saw weekly volatility of 17.10% and 6.90% over the past month.
Equity Research firms currently have a positive stance on shares of Aimmune Therapeutics, Inc. (NASDAQ:AIMT). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.60. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $36.80 on a short term basis.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT) shares typically trade an average volume of 286.20 and institutions hold 82.60% of the total shares.
We see here that the stock is 1.07% away from the 20-Day Simple Moving Average. Their 50-Day Simple Moving Average is a difference of 9.05% from current levels. Further back, their 200-Day Simple Moving Average is 5.80% difference from today’s price. Currently, the stock is -2.93% from its 50-Day High and 34.75% from the 50-day low.
Aimmune Therapeutics, Inc. (NASDAQ:AIMT)‘s stock has performed at 5.23%. Breaking that down further, it has performed -0.37% for the week, 3.76% for the month, 11.73% over the last quarter, 14.90% for the past half-year and 69.05% for this last year.